Ukrain (NSC-631570) in the treatment of pancreas cancer

Drugs under Experimental and Clinical Research

Volumn 26, Issue 5-6, 2000, Pages 179-190

  Zemskov, V S ^a   Procopchuk, O L ^a   Susak, Y M ^a   Zemskov, S V ^a   Hodysh, Y Y ^a   Zemskova, M V ^a  

^a Kyiv Ctr Hepato Panc Billary Surg   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN; UKRAIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PANCREAS CARCINOMA; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BERBERINE ALKALOIDS; BODY WEIGHT; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PANCREATIC NEOPLASMS; PHENANTHRIDINES; PILOT PROJECTS; SURVIVAL ANALYSIS;

EID: 0034446264     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chemotherapy of adenocarcinoma of the pancreas
2. Palliative and supportive care of patients with pancreas cancer
3. Phase II trial of gemcitabine (2′,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
5. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain
6. Preliminary report on clinical experience in the use of Ukrain
7. Clinical studies of Ukrain in terminal cancer patients (phase II)
8. Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain)
9. Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy)
10. The effect of Ukrain on cancer of the urinary bladder
11. Macroscopic UV-marking through affinity
12. Ukrain is selectively cytostatic and/or cytotoxic to human tumor and HIV-infected cells but not to normal human cells
13. Influence of Ukrain on human xenografts in vitro
14. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570)
15. Ukrain (NSC-631570) inhibits angiogenic differentiation of human endothelial cells in vitro
16. Comparison of chemotherapy and x-ray therapy with Ukrain monotherapy for colorectal cancer